Pharmacogenomics at the Center of Precision Medicine: Challenges and Perspective in an Era of Big Data

Dragan Primorac(Lee College), Lidija Bach‐Rojecky(University of Zagreb), Dalia Vađunec(University of Zagreb), Alen Juginović(University of Split), Katarina Žunić(Pliva (Croatia)), Vid Matišić(University of Zagreb), Andrea Skelin(Genos (Croatia)), Borna Arsov(University of Zagreb), Luka Boban(University of Zagreb), Damir Erceg(Children's Hospital Srebrnjak), Ivana Erceg Ivkošić(University of Osijek), Vilim Molnar(University of Zagreb), Jasmina Ćatić(University Hospital Dubrava), Ivan Mikula(University North), Ljubica Boban(University of Zagreb), Lara Primorac(University of Pennsylvania), Bernard Esquivel(IDEO (United States)), Morgan Donaldson(IDEO (United States))
Pharmacogenomics
January 1, 2020
Cited by 66Open Access
Full Text

Abstract

Pharmacogenomics (PGx) is one of the core elements of personalized medicine. PGx information reduces the likelihood of adverse drug reactions and optimizes therapeutic efficacy. St Catherine Specialty Hospital in Zagreb/Zabok, Croatia has implemented a personalized patient approach using the RightMed® Comprehensive PGx panel of 25 pharmacogenes plus Facor V Leiden, Factor II and MTHFR genes, which is interpreted by a special counseling team to offer the best quality of care. With the advent of significant technological advances comes another challenge: how can we harness the data to inform clinically actionable measures and how can we use it to develop better predictive risk models? We propose to apply the principles artificial intelligence to develop a medication optimization platform to prevent, manage and treat different diseases.


Related Papers

No related papers found

Powered by citation graph analysis